THRIVER-F: Feasibility of high-flow transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) in children and adults undergoing surgery under general anaesthesia

Not Applicable

Completed

• Conditions: Surgical patients; Anaesthesiology - Anaesthetics

• Registration Number: ACTRN12616001433493
• Lead Sponsor: The University of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-10-14
• Study Completion: 2019-09-09
• Last Update Posted: 16 November 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 199

Inclusion Criteria

1.aged 10 years or older
2.having elective surgery under general anesthesia with intravenous induction in the study ORs with a participating anesthetist
3.planned use of an endotracheal tube or a supraglottic airway device.
4.scheduled start of anesthesia during working hours
5.willing to provide informed consent

Exclusion Criteria

1.Known contraindication to Optiflow Trademark device
2.Undergoing an operation on the acute list for which they have not been appropriately fasted
3.More than 50% (as judged by the anesthetist) of the nares occluded by the nasal prongs
4.Bleeding in nose or oropharynx
5.Situations in which continuous positive airway pressure (CPAP) is contraindicated
6.Pre-existing nasal obstruction
7.Pre-existing hypoxemia

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ease of use measured by anesthetists on a visual analogue scale with an optional free comments box. [Completed for the peri-induction period, this questionnaire will be filled out by anaesthetists once the peri-induction period is complete and when workload allows];Comfort assessed by patients using a visual analogue scale with an optional free comments box. [The participant will complete this prior to induction of anaesthesia.]